Correlation Between Visa and Lisata Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Visa and Lisata Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Lisata Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and Lisata Therapeutics, you can compare the effects of market volatilities on Visa and Lisata Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Lisata Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Lisata Therapeutics.

Diversification Opportunities for Visa and Lisata Therapeutics

-0.28
  Correlation Coefficient

Very good diversification

The 3 months correlation between Visa and Lisata is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Lisata Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lisata Therapeutics and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Lisata Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lisata Therapeutics has no effect on the direction of Visa i.e., Visa and Lisata Therapeutics go up and down completely randomly.

Pair Corralation between Visa and Lisata Therapeutics

Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.34 times more return on investment than Lisata Therapeutics. However, Visa Class A is 2.92 times less risky than Lisata Therapeutics. It trades about 0.36 of its potential returns per unit of risk. Lisata Therapeutics is currently generating about 0.0 per unit of risk. If you would invest  28,365  in Visa Class A on August 29, 2024 and sell it today you would earn a total of  3,105  from holding Visa Class A or generate 10.95% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Visa Class A  vs.  Lisata Therapeutics

 Performance 
       Timeline  
Visa Class A 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Visa showed solid returns over the last few months and may actually be approaching a breakup point.
Lisata Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Lisata Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Lisata Therapeutics is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Visa and Lisata Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Visa and Lisata Therapeutics

The main advantage of trading using opposite Visa and Lisata Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Lisata Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lisata Therapeutics will offset losses from the drop in Lisata Therapeutics' long position.
The idea behind Visa Class A and Lisata Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios